PMS11 INFLIXIMAB COSTS AND REASONS FOR TREATMENT DISCONTINUATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TREATMENT IN U.S. HOSPITALS: 2012-2015
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1122
https://www.valueinhealthjournal.com/article/S1098-3015(19)31314-2/fulltext
Title :
PMS11 INFLIXIMAB COSTS AND REASONS FOR TREATMENT DISCONTINUATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TREATMENT IN U.S. HOSPITALS: 2012-2015
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31314-2&doi=10.1016/j.jval.2019.04.1122
First page :
Section Title :
Open access? :
No
Section Order :
10645